Escape from telomere-driven crisis is DNA ligase III dependent

Cell Reports

Volumn 8, Issue 4, 2014, Pages 1063-1076

  Jones, Rhiannon E ^a   Oh, Sehyun ^b   Grimstead, Julia W ^a   Zimbric, Jacob ^b   Roger, Laureline ^a   Heppel, Nicole H ^a   Ashelford, Kevin E ^a   Liddiard, Kate ^a   Hendrickson, Eric A ^b   Baird, Duncan M ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA LIGASE III; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; TELOMERASE; UNCLASSIFIED DRUG; XRCC1 PROTEIN; DNA LIGASE;

ALTERNATIVE NONHOMOLOGOUS END JOINING; APOPTOSIS; ARTICLE; CELL GROWTH; CELL SELECTION; CELL SPECIFICITY; CELL VIABILITY; CHROMOSOMAL PARAMETERS; CHROMOSOMES AND CHROMOSOMAL PHENOMENA; CLASSICAL NONHOMOLOGOUS END JOINING; CONTROLLED STUDY; DNA END JOINING REPAIR; ENZYME ACTIVITY; ENZYME INDUCTION; GENE AMPLIFICATION; GENE DELETION; GENE LOCUS; GENE REARRANGEMENT; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; INTERCHROMOSOMAL FUSION; INTRACHROMOSOMAL FUSION; MULTINUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; TELOMERE; TELOMERE EROSION; TELOMERE HOMEOSTASIS; ANIMAL CELL; CELL CYCLE CHECKPOINT; CELL FUSION; ENZYME INHIBITION; MOUSE; NONHUMAN; PROTEIN PROTEIN INTERACTION; SHORT DYSFUNCTIONAL TELOMERE; ENZYME ACTIVE SITE; GENETIC RECOMBINATION; HCT116 CELL LINE; PHYSIOLOGY;

APOPTOSIS; CATALYTIC DOMAIN; DNA END-JOINING REPAIR; DNA LIGASES; HCT116 CELLS; HUMANS; RECOMBINATION, GENETIC; TELOMERE HOMEOSTASIS;

EID: 84908357050     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.07.007     Document Type: Article

References (69)

1. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J.Mol. Biol. 1990, 215:403-410.
2. Artandi S.E., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L., DePinho R.A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000, 406:641-645.
3. Baird D.M., Rowson J., Wynford-Thomas D., Kipling D. Extensive allelic variation and ultrashort telomeres in senescent human cells. Nat. Genet. 2003, 33:203-207.
4. Boboila C., Yan C., Wesemann D.R., Jankovic M., Wang J.H., Manis J., Nussenzweig A., Nussenzweig M., Alt F.W. Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4. J.Exp. Med. 2010, 207:417-427.
5. Boboila C., Oksenych V., Gostissa M., Wang J.H., Zha S., Zhang Y., Chai H., Lee C.S., Jankovic M., Saez L.M., et al. Robust chromosomal DNA repair via alternative end-joining in the absence of X-ray repair cross-complementing protein 1 (XRCC1). Proc. Natl. Acad. Sci. USA 2012, 109:2473-2478.
6. Boulton S.J., Jackson S.P. Identification of a Saccharomyces cerevisiae Ku80 homologue: roles in DNA double strand break rejoining and in telomeric maintenance. Nucleic Acids Res. 1996, 24:4639-4648.
7. Brunet E., Simsek D., Tomishima M., DeKelver R., Choi V.M., Gregory P., Urnov F., Weinstock D.M., Jasin M. Chromosomal translocations induced at specified loci in human stem cells. Proc. Natl. Acad. Sci. USA 2009, 106:10620-10625.
8. Bunting S.F., Nussenzweig A. End-joining, translocations and cancer. Nat. Rev. Cancer 2013, 13:443-454.
9. Caldecott K.W. Protein-protein interactions during mammalian DNA single-strand break repair. Biochem. Soc. Trans. 2003, 31:247-251.
10. Caldecott K.W., McKeown C.K., Tucker J.D., Ljungquist S., Thompson L.H. An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III. Mol. Cell. Biol. 1994, 14:68-76.
11. Campbell P.J., Yachida S., Mudie L.J., Stephens P.J., Pleasance E.D., Stebbings L.A., Morsberger L.A., Latimer C., McLaren S., Lin M.L., et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010, 467:1109-1113.
12. Capper R., Britt-Compton B., Tankimanova M., Rowson J., Letsolo B., Man S., Haughton M., Baird D.M. The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev. 2007, 21:2495-2508.
13. Celli G.B., Denchi E.L., de Lange T. Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat. Cell Biol. 2006, 8:885-890.
14. Chai W., Du Q., Shay J.W., Wright W.E. Human telomeres havedifferent overhang sizes at leading versus lagging strands. Mol. Cell 2006, 21:427-435.
15. Chen X., Zhong S., Zhu X., Dziegielewska B., Ellenberger T., Wilson G.M., MacKerell A.D., Tomkinson A.E. Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair. Cancer Res. 2008, 68:3169-3177.
16. Counter C.M., Avilion A.A., LeFeuvre C.E., Stewart N.G., Greider C.W., Harley C.B., Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 1992, 11:1921-1929.
17. Cuneo M.J., Gabel S.A., Krahn J.M., Ricker M.A., London R.E. The structural basis for partitioning of the XRCC1/DNA ligase III-α BRCT-mediated dimer complexes. Nucleic Acids Res. 2011, 39:7816-7827.
18. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003, 426:194-198.
19. Daley J.M., Wilson T.E. Rejoining of DNA double-strand breaks as a function of overhang length. Mol. Cell. Biol. 2005, 25:896-906.
20. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005, 19:2100-2110.
21. Difilippantonio M.J., Petersen S., Chen H.T., Johnson R., Jasin M., Kanaar R., Ried T., Nussenzweig A. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J.Exp. Med. 2002, 196:469-480.
22. Difilippantonio S., Gapud E., Wong N., Huang C.Y., Mahowald G., Chen H.T., Kruhlak M.J., Callen E., Livak F., Nussenzweig M.C., et al. 53BP1 facilitates long-range DNA end-joining during V(D)J recombination. Nature 2008, 456:529-533.
23. Dimitrova N., Chen Y.C., Spector D.L., de Lange T. 53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility. Nature 2008, 456:524-528.
24. Dulic A., Bates P.A., Zhang X., Martin S.R., Freemont P.S., Lindahl T., Barnes D.E. BRCT domain interactions in the heterodimeric DNA repair protein XRCC1-DNA ligase III. Biochemistry 2001, 40:5906-5913.
25. Dynan W.S., Yoo S. Interaction of Ku protein and DNA-dependent protein kinase catalytic subunit with nucleic acids. Nucleic Acids Res. 1998, 26:1551-1559.
26. Ellenberger T., Tomkinson A.E. Eukaryotic DNA ligases: structural and functional insights. Annu. Rev. Biochem. 2008, 77:313-338.
27. Feldmann E., Schmiemann V., Goedecke W., Reichenberger S., Pfeiffer P. DNA double-strand break repair in cell-free extracts from Ku80-deficient cells: implications for Ku serving as an alignment factor in non-homologous DNA end joining. Nucleic Acids Res. 2000, 28:2585-2596.
28. Gavathiotis E., Heald R.A., Stevens M.F., Searle M.S. Drug recognition and stabilisation of the parallel-stranded DNA quadruplex d(TTAGGGT)4 containing the human telomeric repeat. J.Mol. Biol. 2003, 334:25-36.
29. Guirouilh-Barbat J., Huck S., Bertrand P., Pirzio L., Desmaze C., Sabatier L., Lopez B.S. Impact of the KU80 pathway on NHEJ-induced genome rearrangements in mammalian cells. Mol. Cell 2004, 14:611-623.
30. Hahn W.C., Stewart S.A., Brooks M.W., York S.G., Eaton E., Kurachi A., Beijersbergen R.L., Knoll J.H., Meyerson M., Weinberg R.A. Inhibition of telomerase limits the growth of human cancer cells. Nat. Med. 1999, 5:1164-1170.
31. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
32. Hendrickson E.A. Gene targeting in human somatic cells. Sourcebook of Models for Biomedical Research 2008, 509-525. Humana Press, Totowa, NJ. M. Conn (Ed.).
33. Heng, L. (2013). Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv:1303.3997v2 [q-bio.GN].
34. Khan I.F., Hirata R.K., Russell D.W. AAV-mediated gene targeting methods for human cells. Nat. Protoc. 2011, 6:482-501.
35. Letsolo B.T., Rowson J., Baird D.M. Fusion of short telomeres in human cells is characterized by extensive deletion and microhomology, and can result in complex rearrangements. Nucleic Acids Res. 2010, 38:1841-1852.
36. Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R. The sequence alignment/map format and SAMtools. Bioinformatics 2009, 25:2078-2079. 1000 Genome Project Data Processing Subgroup.
37. Lieber M.R. The mechanism of human nonhomologous DNA end joining. J.Biol. Chem. 2008, 283:1-5.
38. Lin T.T., Letsolo B.T., Jones R.E., Rowson J., Pratt G., Hewamana S., Fegan C., Pepper C., Baird D.M. Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis. Blood 2010, 116:1899-1907.
39. Lo A.W., Sabatier L., Fouladi B., Pottier G., Ricoul M., Murnane J.P. DNA amplification by breakage/fusion/bridge cycles initiated by spontaneous telomere loss in a human cancer cell line. Neoplasia 2002, 4:531-538.
40. Lohse M., Bolger A.M., Nagel A., Fernie A.R., Lunn J.E., Stitt M., Usadel B. RobiNA: a user-friendly, integrated software solution for RNA-Seq-based transcriptomics. Nucleic Acids Res. 2012, 40:W622-W627.
41. Maser R.S., Wong K.K., Sahin E., Xia H., Naylor M., Hedberg H.M., Artandi S.E., DePinho R.A. DNA-dependent protein kinase catalytic subunit is not required for dysfunctional telomere fusion and checkpoint response in the telomerase-deficient mouse. Mol. Cell. Biol. 2007, 27:2253-2265.
42. Masson M., Niedergang C., Schreiber V., Muller S., Menissier-de Murcia J., de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol. Cell. Biol. 1998, 18:3563-3571.
43. Meeker A.K., Hicks J.L., Iacobuzio-Donahue C.A., Montgomery E.A., Westra W.H., Chan T.Y., Ronnett B.M., De Marzo A.M. Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin. Cancer Res. 2004, 10:3317-3326.
44. Murnane J.P. Telomere dysfunction and chromosome instability. Mutat. Res. 2012, 730:28-36.
45. Oh S., Wang Y., Zimbric J., Hendrickson E.A. Human LIGIV is synthetically lethal with the loss of Rad54B-dependent recombination and is required for certain chromosome fusion events induced by telomere dysfunction. Nucleic Acids Res. 2013, 41:1734-1749.
46. Oh S., Harvey A., Zimbric J., Wang Y., Nguyen T., Jackson P.J., Hendrickson E.A. DNA ligase III and DNA ligase IV carry out genetically distinct forms of end joining in human somatic cells. DNA Repair (Amst.) 2014, 10.1016/j.dnarep.2014.04.015.
47. Preto A., Singhrao S.K., Haughton M.F., Kipling D., Wynford-Thomas D., Jones C.J. Telomere erosion triggers growth arrest but not cell death in human cancer cells retaining wild-type p53: implications for antitelomerase therapy. Oncogene 2004, 23:4136-4145.
48. Rai R., Zheng H., He H., Luo Y., Multani A., Carpenter P.B., Chang S. The function of classical and alternative non-homologous end-joining pathways in the fusion of dysfunctional telomeres. EMBO J. 2010, 29:2598-2610.
49. Roger L., Jones R.E., Heppel N.H., Williams G.T., Sampson J.R., Baird D.M. Extensive telomere erosion in the initiation of colorectal adenomas and its association with chromosomal instability. J.Natl. Cancer Inst. 2013, 105:1202-1211.
50. Sabatier L., Ricoul M., Pottier G., Murnane J.P. The loss of a single telomere can result in instability of multiple chromosomes in a human tumor cell line. Mol. Cancer Res. 2005, 3:139-150.
51. Sallmyr A., Tomkinson A.E., Rassool F.V. Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks. Blood 2008, 112:1413-1423.
52. Sfeir A., de Lange T. Removal of shelterin reveals the telomere end-protection problem. Science 2012, 336:593-597.
53. Shih I.M., Zhou W., Goodman S.N., Lengauer C., Kinzler K.W., Vogelstein B. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res. 2001, 61:818-822.
54. Simsek D., Jasin M. DNA ligase III: a spotty presence in eukaryotes, but an essential function where tested. Cell Cycle 2011, 10:3636-3644.
55. Simsek D., Brunet E., Wong S.Y., Katyal S., Gao Y., McKinnon P.J., Lou J., Zhang L., Li J., Rebar E.J., et al. DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation. PLoS Genet. 2011, 7:e1002080.
56. Simsek D., Furda A., Gao Y., Artus J., Brunet E., Hadjantonakis A.K., Van Houten B., Shuman S., McKinnon P.J., Jasin M. Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair. Nature 2011, 471:245-248.
57. Smogorzewska A., Karlseder J., Holtgreve-Grez H., Jauch A., de Lange T. DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2. Curr. Biol. 2002, 12:1635-1644.
58. Symington L.S., Gautier J. Double-strand break end resection and repair pathway choice. Annu. Rev. Genet. 2011, 45:247-271.
59. Tanaka H., Bergstrom D.A., Yao M.C., Tapscott S.J. Widespread and nonrandom distribution of DNA palindromes in cancer cells provides a structural platform for subsequent gene amplification. Nat. Genet. 2005, 37:320-327.
60. Tankimanova M., Capper R., Letsolo B.T., Rowson J., Jones R.E., Britt-Compton B., Taylor A.M., Baird D.M. Mre11 modulates the fidelity of fusion between short telomeres in human cells. Nucleic Acids Res. 2012, 40:2518-2526.
61. Tobin L.A., Robert C., Nagaria P., Chumsri S., Twaddell W., Ioffe O.B., Greco G.E., Brodie A.H., Tomkinson A.E., Rassool F.V. Targeting abnormal DNA repair in therapy-resistant breast cancers. Mol. Cancer Res. 2012, 10:96-107.
62. van Gent D.C., Hoeijmakers J.H., Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nat. Rev. Genet. 2001, 2:196-206.
63. van Steensel B., Smogorzewska A., de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 1998, 92:401-413.
64. Yan C.T., Boboila C., Souza E.K., Franco S., Hickernell T.R., Murphy M., Gumaste S., Geyer M., Zarrin A.A., Manis J.P., et al. IgH class switching and translocations use a robust non-classical end-joining pathway. Nature 2007, 449:478-482.
65. Zerbino D.R., Birney E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 2008, 18:821-829.
66. Zhang Y., Jasin M. An essential role for CtIP in chromosomal translocation formation through an alternative end-joining pathway. Nat. Struct. Mol. Biol. 2011, 18:80-84.
67. Zhang A., Zheng C., Lindvall C., Hou M., Ekedahl J., Lewensohn R., Yan Z., Yang X., Henriksson M., Blennow E., et al. Frequent amplification of the telomerase reverse transcriptase gene in human tumors. Cancer Res. 2000, 60:6230-6235.
68. Zhu C., Mills K.D., Ferguson D.O., Lee C., Manis J., Fleming J., Gao Y., Morton C.C., Alt F.W. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 2002, 109:811-821.
69. Zschenker O., Kulkarni A., Miller D., Reynolds G.E., Granger-Locatelli M., Pottier G., Sabatier L., Murnane J.P. Increased sensitivity of subtelomeric regions to DNA double-strand breaks in a human cancer cell line. DNA Repair (Amst.) 2009, 8:886-900.